Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Mayur Brahmania, Alexander Kuo, Elliot B. Tapper, Michael Völk, Jennifer Vittorio, Marwan Ghabril, Timothy R. Morgan, Fasiha Kanwal, Neehar D. Parikh, Paul Martin, Shivang Mehta, Gerald Scott Winder, Gene Y. Im, David S. Goldberg, Jennifer C. Lai, Andrés Duarte‐Rojo, Angelo H. Paredes, Arpan Patel, Amandeep Sahota, Lisa M. McElroy, Charlie Thomas, Anji Wall, Maricar Malinis, Saima Aslam, Douglas A. Simonetto, Nneka N. Ufere, Sudha Ramakrishnan, Mary M. Flynn, Yasmin Ibrahim, Sumeet K. Asrani, Marina Serper
Abstract
The liver transplantation (LT) evaluation and waitlisting process is subject to variations in care that can impede quality. The American Association for the Study of Liver Diseases (AASLD) Practice Metrics Committee (PMC) developed quality measures and patient-reported experience measures along the continuum of pre-LT care to reduce care variation and guide patient-centered care. Following a systematic literature review, candidate pre-LT measures were grouped into 4 phases of care: referral, evaluation and waitlisting, waitlist management, and organ acceptance. A modified Delphi panel with content expertise in hepatology, transplant surgery, psychiatry, transplant infectious disease, palliative care, and social work selected the final set. Candidate patient-reported experience measures spanned domains of cognitive health, emotional health, social well-being, and understanding the LT process. Of the 71 candidate measures, 41 were selected: 9 for referral; 20 for evaluation and waitlisting; 7 for waitlist management; and 5 for organ acceptance. A total of 14 were related to structure, 17 were process measures, and 10 were outcome measures that focused on elements not typically measured in routine care. Among the patient-reported experience measures, candidates of LT rated items from understanding the LT process domain as the most important. The proposed pre-LT measures provide a framework for quality improvement and care standardization among candidates of LT. Select measures apply to various stakeholders such as referring practitioners in the community and LT centers. Clinically meaningful measures that are distinct from those used for regulatory transplant reporting may facilitate local quality improvement initiatives to improve access and quality of care.